30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

AIM ImmunoTech Inc (AIM)

Track

Stock chart
Ticker: AIM Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Equels Thomas K
CEO & President
1 purchase — total 824 USD
Buy 13 Jun 2025
Value US$3,170,510.77 | Price 146.17 | Shares 14,818
Buy 12 Jun 2025
Value US$2,193,444.32 | Price 439.40 | Shares 19,701
Buy 11 Apr 2025
Value US$50,000.00 | Price 0.03 | Shares 1,968,504
Buy 11 Apr 2025
Value US$5,000.02 | Price 0.03 | Shares 196,851
Buy 11 Apr 2025
Value US$50,000.00 | Price 0.03 | Shares 1,968,504
Buy 4 Apr 2025
Value US$2,583.00 | Price 0.06 | Shares 41,000
Buy 4 Apr 2025
Value US$43.50 | Price 0.09 | Shares 500
Buy 5 Mar 2025
Value US$6,730.00 | Price 0.13 | Shares 50,000
Buy 4 Mar 2025
Value US$5,060.00 | Price 0.12 | Shares 44,000
Buy 4 Mar 2025
Value US$10,000.08 | Price 0.12 | Shares 83,334
Sale 19 Dec 2024
Value US$883.94 | Price 0.19 | Shares 4,580
Buy 18 Dec 2024
Value US$4,681.76 | Price 0.21 | Shares 22,727
Buy 2 Dec 2024
Value US$2,355.53 | Price 0.21 | Shares 11,111
Buy 21 Nov 2024
Value US$4,240.00 | Price 0.21 | Shares 20,000
Buy 20 Nov 2024
Value US$15,816.93 | Price 0.19 | Shares 81,953
Buy 20 Nov 2024
Value US$16,915.00 | Price 0.20 | Shares 85,000
Buy 20 Nov 2024
Value US$11,000.13 | Price 0.18 | Shares 60,110
Buy 16 Sep 2024
Value US$1,515.00 | Price 0.30 | Shares 5,000
Buy 13 Sep 2024
Value US$6,160.00 | Price 0.31 | Shares 20,000
Buy 6 May 2024
Value US$25,000.24 | Price 0.41 | Shares 61,729
Buy 6 May 2024
Value US$25,000.24 | Price 0.41 | Shares 61,729
Buy 6 May 2024
Value US$12,500.32 | Price 0.41 | Shares 30,865
Buy 21 Mar 2024
Value US$15,000.18 | Price 0.39 | Shares 38,462
Buy 15 Mar 2024
Value US$25,000.14 | Price 0.33 | Shares 75,758
Buy 15 Mar 2024
Value US$30,000.30 | Price 0.33 | Shares 90,910
Buy 15 Mar 2024
Value US$12,500.07 | Price 0.33 | Shares 37,879
Buy 27 Nov 2023
Value US$15,000.42 | Price 0.44 | Shares 33,861
Buy 29 Sep 2023
Value US$10,000.12 | Price 0.44 | Shares 22,676
Buy 25 Aug 2023
Value US$5,500.52 | Price 0.67 | Shares 8,222
Buy 24 Aug 2023
Value US$10,000.33 | Price 0.67 | Shares 14,993
Buy 17 Jul 2023
Value US$10,000.50 | Price 0.59 | Shares 16,950
Buy 3 Jan 2023
Value US$25,000.26 | Price 0.31 | Shares 80,646
Buy 3 Jan 2023
Value US$50,000.21 | Price 0.31 | Shares 161,291
Buy 3 Jan 2023
Value US$25,000.26 | Price 0.31 | Shares 80,646
Buy 25 Feb 2021
Value US$24,999.30 | Price 2.35 | Shares 10,638
Buy 24 Feb 2021
Value US$25,000.12 | Price 2.26 | Shares 11,062
Buy 17 Dec 2020
Value US$25,000.20 | Price 1.72 | Shares 14,535
Buy 3 Sep 2020
Value US$25,001.48 | Price 2.03 | Shares 12,316
Buy 21 Aug 2020
Value US$25,000.90 | Price 2.33 | Shares 10,730
Buy 27 Jun 2019
Value US$11,501.84 | Price 4.37 | Shares 2,632
Buy 21 Jun 2019
Value US$35,040.85 | Price 4.03 | Shares 8,695
Buy 21 Jun 2019
Value US$9,998.43 | Price 4.03 | Shares 2,481
Buy 21 Jun 2019
Value US$38,998.31 | Price 4.03 | Shares 9,677
Buy 21 Jun 2019
Value US$38,998.31 | Price 4.03 | Shares 9,677
Buy 21 Jun 2019
Value US$21,000.33 | Price 4.03 | Shares 5,211
Buy 21 Jun 2019
Value US$118,498.12 | Price 4.03 | Shares 29,404
Buy 19 Mar 2019
Value US$2,351.70 | Price 0.18 | Shares 13,400
Buy 30 Nov 2018
Value US$1,176.00 | Price 0.20 | Shares 6,000
Buy 30 Nov 2018
Value US$64.96 | Price 0.19 | Shares 334
Buy 30 Nov 2018
Value US$58.32 | Price 0.19 | Shares 300
Buy 30 Nov 2018
Value US$9.69 | Price 0.19 | Shares 50
Buy 30 Nov 2018
Value US$463.20 | Price 0.19 | Shares 2,400
Buy 30 Nov 2018
Value US$1,815.83 | Price 0.19 | Shares 9,557
Buy 30 Nov 2018
Value US$0.95 | Price 0.19 | Shares 5
Buy 30 Nov 2018
Value US$256.04 | Price 0.19 | Shares 1,354
Buy 5 Nov 2018
Value US$5,552.36 | Price 0.22 | Shares 25,238
Buy 26 Oct 2018
Value US$710.50 | Price 0.20 | Shares 3,500
Buy 25 Oct 2018
Value US$20,000.00 | Price 0.20 | Shares 100,000
Buy 27 Jul 2018
Value US$10,000.07 | Price 0.29 | Shares 34,483
Buy 24 Jul 2018
Value US$39,060.00 | Price 0.31 | Shares 126,000
Buy 23 Jul 2018
Value US$10,000.29 | Price 0.31 | Shares 32,259
Buy 23 Jul 2018
Value US$35,000.24 | Price 0.31 | Shares 112,904
Buy 23 Jul 2018
Value US$10,000.29 | Price 0.31 | Shares 32,259
Buy 27 Apr 2018
Value US$32,000.00 | Price 0.32 | Shares 100,000
Buy 27 Apr 2018
Value US$10,240.00 | Price 0.32 | Shares 32,000
Buy 2 May 2017
Value US$9,999.99 | Price 0.63 | Shares 15,873
Buy 2 May 2017
Value US$9,999.99 | Price 0.63 | Shares 15,873
Buy 2 May 2017
Value US$9,999.99 | Price 0.63 | Shares 15,873
Buy 2 May 2017
Value US$5,000.31 | Price 0.63 | Shares 7,937
Buy 27 Apr 2017
Value US$50,000.16 | Price 0.69 | Shares 72,464
Buy 11 Apr 2017
Value US$100,000.00 | Price 0.50 | Shares 200,000
Buy 16 Feb 2017
Value US$3,211.26 | Price 0.46 | Shares 6,981
Buy 16 Feb 2017
Value US$3,686.44 | Price 0.46 | Shares 8,014
Buy 16 Feb 2017
Value US$4,550.32 | Price 0.46 | Shares 9,892
Buy 22 Dec 2016
Value US$49,999.89 | Price 0.73 | Shares 68,493
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-16 2025-06-13 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
14,818 +11.5%
146.17
US$3,170,511 		14,818 +11.5% 146.17 US$3,170,511
2025-06-13 2025-06-12 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
19,701 +48.3%
439.40
US$2,193,444 		19,701 +48.3% 439.40 US$2,193,444
2025-04-23 2025-04-11 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
3,963 +26.9%
214.10
US$1,982,091 		3,963 +26.9% 214.10 US$1,982,091
2025-04-23 2025-04-11 B Purchase
1.4
MITCHELL WILLIAM M
Non-Executive Director
196,851 +60.6%
0.03
US$5,000 		196,851 +60.6% 0.03 US$5,000
2025-04-23 2025-04-11 B Purchase
3.1
KELLNER TED D
Non-Executive Director
1,968,504 +196850.4%
0.03
US$50,000 		1,968,504 +196850.4% 0.03 US$50,000
2025-04-07 2025-04-04 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
41,000 +2.2%
0.06
US$2,583 		41,000 +2.2% 0.06 US$2,583
2025-04-04 2025-04-04 B Purchase
2.8
Rodino Peter W III

COO, Secretary, Gen. Counsel

Officer
500 +0.1%
0.09
US$44 		500 +0.1% 0.09 US$44
2025-03-06 2025-03-05 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
50,000 +2.8%
0.13
US$6,730 		50,000 +2.8% 0.13 US$6,730
2025-03-05 2025-03-04 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
44,000 +2.5%
0.12
US$5,060 		44,000 +2.5% 0.12 US$5,060
2025-03-04 2025-03-04 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
83,334 +5.0%
0.12
US$10,000 		83,334 +5.0% 0.12 US$10,000
2024-12-20 2024-12-19 S Sale
1.4
MITCHELL WILLIAM M
Non-Executive Director
4,580 -3.7%
0.19
US$884 		4,580 -3.7% 0.19 US$884
2024-12-19 2024-12-18 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
22,727 +1.4%
0.21
US$4,682 		22,727 +1.4% 0.21 US$4,682
2024-12-04 2024-12-02 B Purchase
2.8
APPELROUTH STEWART
Non-Executive Director
11,111 +3.2%
0.21
US$2,356 		11,111 +3.2% 0.21 US$2,356
2025-01-21 2024-11-21 B Purchase Equels Thomas K

CEO & President

Executive Director
20,000 +1.2%
0.21
US$4,240 		20,000 +1.2% 0.21 US$4,240
2024-11-21 2024-11-20 B Purchase
2.8
APPELROUTH STEWART
Non-Executive Director
81,953 +34.2%
0.19
US$15,817 		81,953 +34.2% 0.19 US$15,817
2024-11-21 2024-11-20 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
85,000 +5.5%
0.20
US$16,915 		85,000 +5.5% 0.20 US$16,915
2024-11-20 2024-11-20 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
60,110 +4.0%
0.18
US$11,000 		60,110 +4.0% 0.18 US$11,000
2024-09-17 2024-09-16 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
5,000 +0.3%
0.30
US$1,515 		5,000 +0.3% 0.30 US$1,515
2024-09-16 2024-09-13 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
20,000 +1.4%
0.31
US$6,160 		20,000 +1.4% 0.31 US$6,160
2024-05-07 2024-05-06 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
61,729 +8.6%
0.41
US$25,000 		61,729 +8.6% 0.41 US$25,000
2024-05-07 2024-05-06 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
61,729 +8.6%
0.41
US$25,000 		61,729 +8.6% 0.41 US$25,000
2024-05-07 2024-05-06 B Purchase
2.8
Rodino Peter W III

COO, Secretary, Gen. Counsel

Officer
30,865 +17.0%
0.41
US$12,500 		30,865 +17.0% 0.41 US$12,500
2024-03-22 2024-03-21 B Purchase
2.2
BRYAN NANCY
Non-Executive Director
38,462 +inf%
0.39
US$15,000 		38,462 +inf% 0.39 US$15,000
2024-03-18 2024-03-15 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
75,758 +11.8%
0.33
US$25,000 		75,758 +11.8% 0.33 US$25,000
2024-03-18 2024-03-15 B Purchase
2.8
APPELROUTH STEWART
Non-Executive Director
90,910 +61.1%
0.33
US$30,000 		90,910 +61.1% 0.33 US$30,000
2024-03-18 2024-03-15 B Purchase
2.8
Rodino Peter W III

COO, Secretary, Gen. Counsel

Officer
37,879 +26.3%
0.33
US$12,500 		37,879 +26.3% 0.33 US$12,500
2023-11-27 2023-11-27 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
33,861 +5.6%
0.44
US$15,000 		33,861 +5.6% 0.44 US$15,000
2023-09-29 2023-09-29 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
22,676 +3.9%
0.44
US$10,000 		22,676 +3.9% 0.44 US$10,000
2023-08-25 2023-08-25 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
8,222 +1.4%
0.67
US$5,501 		8,222 +1.4% 0.67 US$5,501
2023-08-24 2023-08-24 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
14,993 +2.7%
0.67
US$10,000 		14,993 +2.7% 0.67 US$10,000
2023-07-17 2023-07-17 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
16,950 +3.1%
0.59
US$10,000 		16,950 +3.1% 0.59 US$10,000
2023-01-04 2023-01-03 B Purchase
2.8
APPELROUTH STEWART
Non-Executive Director
80,646 +59.1%
0.31
US$25,000 		80,646 +59.1% 0.31 US$25,000
2023-01-04 2023-01-03 B Purchase
3.3
Equels Thomas K

CEO & President

Executive Director
161,291 +42.1%
0.31
US$50,000 		161,291 +42.1% 0.31 US$50,000
2023-01-04 2023-01-03 B Purchase
2.8
Rodino Peter W III

COO, Secretary, Gen. Counsel

Officer
80,646 +127.6%
0.31
US$25,000 		80,646 +127.6% 0.31 US$25,000
2021-02-25 2021-02-25 B Purchase
2.8
APPELROUTH STEWART
Non-Executive Director
10,638 +13.0%
2.35
US$24,999 		10,638 +13.0% 2.35 US$24,999
2021-02-24 2021-02-24 B Purchase
3.3
EQUELS THOMAS K.

CEO & President

Executive Director
11,062 +5.6%
2.26
US$25,000 		11,062 +5.6% 2.26 US$25,000
2020-12-17 2020-12-17 B Purchase
3.3
EQUELS THOMAS K.

CEO

Executive Director
14,535 +7.9%
1.72
US$25,000 		14,535 +7.9% 1.72 US$25,000
2020-09-03 2020-09-03 B Purchase
3.3
EQUELS THOMAS K.

CEO & President

Executive Director
12,316 +7.2%
2.03
US$25,001 		12,316 +7.2% 2.03 US$25,001
2020-08-21 2020-08-21 B Purchase
3.3
EQUELS THOMAS K.

CEO

Executive Director
10,730 +6.7%
2.33
US$25,001 		10,730 +6.7% 2.33 US$25,001
2019-06-27 2019-06-27 B Purchase
3.3
EQUELS THOMAS K.

Exec. Vice Chairman/CEO/Pres.

Executive Director
2,632 +4.4%
4.37
US$11,502 		2,632 +4.4% 4.37 US$11,502
2019-06-25 2019-06-21 B Purchase
2.8
RODINO III PETER W.

Dir Govt Relations/Sectry
8,695 +223.2%
4.03
US$35,041 		8,695 +223.2% 4.03 US$35,041
2019-06-25 2019-06-21 B Purchase
0.5
STRAYER DAVID R

Chief Science/Medical Officer
2,481 +84.4%
4.03
US$9,998 		2,481 +84.4% 4.03 US$9,998
2019-06-25 2019-06-21 B Purchase
2.8
APPELROUTH STEWART
9,677 +56.8%
4.03
US$38,998 		9,677 +56.8% 4.03 US$38,998
2019-06-24 2019-06-21 B Purchase
1.4
MITCHELL WILLIAM M
9,677 +86.7%
4.03
US$38,998 		9,677 +86.7% 4.03 US$38,998
2019-06-24 2019-06-21 B Purchase
0.5
SPRINGATE WAYNE S

Sr. VP of Operations
5,211 +150.6%
4.03
US$21,000 		5,211 +150.6% 4.03 US$21,000
2019-06-21 2019-06-21 B Purchase
3.3
EQUELS THOMAS K.

Exec. Vice Chairman/CEO/Pres.

Executive Director
29,404 +2.2%
4.03
US$118,498 		29,404 +2.2% 4.03 US$118,498
2019-03-19 2019-03-19 B Purchase
3.3
EQUELS THOMAS K.

Exec. Vice Chairman/CEO/Pres.

Executive Director
13,400 +1.7%
0.18
US$2,352 		13,400 +1.7% 0.18 US$2,352
2018-12-03 2018-11-30 B Purchase EQUELS THOMAS K.

Exec. Vice Chairman/CEO/Pres.

Executive Director
6,000 +0.8%
0.20
US$1,176 		6,000 +0.8% 0.20 US$1,176
2018-12-03 2018-11-30 B Purchase EQUELS THOMAS K.

Exec. Vice Chairman/CEO/Pres.

Executive Director
334 +0.0%
0.19
US$65 		334 +0.0% 0.19 US$65
2018-12-03 2018-11-30 B Purchase EQUELS THOMAS K.

Exec. Vice Chairman/CEO/Pres.

Executive Director
300 +0.0%
0.19
US$58 		300 +0.0% 0.19 US$58
2018-12-03 2018-11-30 B Purchase EQUELS THOMAS K.

Exec. Vice Chairman/CEO/Pres.

Executive Director
50 +0.0%
0.19
US$10 		50 +0.0% 0.19 US$10
2018-12-03 2018-11-30 B Purchase EQUELS THOMAS K.

Exec. Vice Chairman/CEO/Pres.

Executive Director
2,400 +0.3%
0.19
US$463 		2,400 +0.3% 0.19 US$463
2018-12-03 2018-11-30 B Purchase EQUELS THOMAS K.

Exec. Vice Chairman/CEO/Pres.

Executive Director
9,557 +1.2%
0.19
US$1,816 		9,557 +1.2% 0.19 US$1,816
2018-12-03 2018-11-30 B Purchase EQUELS THOMAS K.

Exec. Vice Chairman/CEO/Pres.

Executive Director
5
0.19
US$1 		5 0.19 US$1
2018-12-03 2018-11-30 B Purchase EQUELS THOMAS K.

Exec. Vice Chairman/CEO/Pres.

Executive Director
1,354 +0.2%
0.19
US$256 		1,354 +0.2% 0.19 US$256
2018-11-06 2018-11-05 B Purchase APPELROUTH STEWART Non-Executive Director
25,238 +10.4%
0.22
US$5,552 		25,238 +10.4% 0.22 US$5,552
2018-10-29 2018-10-26 B Purchase EQUELS THOMAS K.

Exec. Vice Chairman/CEO/Pres.

Executive Director
3,500 +0.5%
0.20
US$710 		3,500 +0.5% 0.20 US$710
2018-10-25 2018-10-25 B Purchase EQUELS THOMAS K.

Exec. Vice Chairman/CEO/Pres.

Executive Director
100,000 +14.9%
0.20
US$20,000 		100,000 +14.9% 0.20 US$20,000
2018-07-27 2018-07-27 B Purchase EQUELS THOMAS K.

Exec. Vice Chairman/CEO/Pres.

Executive Director
34,483 +5.4%
0.29
US$10,000 		34,483 +5.4% 0.29 US$10,000
2018-07-24 2018-07-24 B Purchase APPELROUTH STEWART Non-Executive Director
126,000 +108.9%
0.31
US$39,060 		126,000 +108.9% 0.31 US$39,060
2018-07-23 2018-07-23 B Purchase PASCALE ADAM

CFO

Officer
32,259 +117.8%
0.31
US$10,000 		32,259 +117.8% 0.31 US$10,000
2018-07-23 2018-07-23 B Purchase EQUELS THOMAS K.

Exec. Vice Chairman/CEO/Pres.

Executive Director
112,904 +21.5%
0.31
US$35,000 		112,904 +21.5% 0.31 US$35,000
2018-07-23 2018-07-23 B Purchase SPRINGATE WAYNE S

Sr. VP of Operations

Officer
32,259 +99.2%
0.31
US$10,000 		32,259 +99.2% 0.31 US$10,000
2018-04-30 2018-04-27 B Purchase APPELROUTH STEWART Non-Executive Director
100,000 +634.9%
0.32
US$32,000 		100,000 +634.9% 0.32 US$32,000
2018-04-30 2018-04-27 B Purchase EQUELS THOMAS K.

CEO, President

Executive Director
32,000 +6.5%
0.32
US$10,240 		32,000 +6.5% 0.32 US$10,240
2017-05-03 2017-05-02 B Purchase Rodino Peter W. III

Exec Dir Govt Relations/Secrty

Officer
15,873 +inf%
0.63
US$10,000 		15,873 +inf% 0.63 US$10,000
2017-05-03 2017-05-02 B Purchase Springate Wayne S.

Sr VP of Operations

Officer
15,873 +95.4%
0.63
US$10,000 		15,873 +95.4% 0.63 US$10,000
2017-05-02 2017-05-02 B Purchase Pascale Adam

CFO

Officer
15,873 +137.8%
0.63
US$10,000 		15,873 +137.8% 0.63 US$10,000
2017-05-02 2017-05-02 B Purchase STRAYER DAVID R

Chief Science/Medical Officer

Officer
7,937 +23.4%
0.63
US$5,000 		7,937 +23.4% 0.63 US$5,000
2017-04-27 2017-04-27 B Purchase Equels Thomas K.

CEO, President

Executive Director
72,464 +17.2%
0.69
US$50,000 		72,464 +17.2% 0.69 US$50,000
2017-04-11 2017-04-11 B Purchase Equels Thomas K.

CEO, President

Executive Director
200,000 +90.7%
0.50
US$100,000 		200,000 +90.7% 0.50 US$100,000
2017-02-21 2017-02-16 B Purchase Pascale Adam

CFO
6,981 +153.9%
0.46
US$3,211 		6,981 +153.9% 0.46 US$3,211
2017-02-21 2017-02-16 B Purchase Springate Wayne S.

Sr VP of Operations
8,014 +33.4%
0.46
US$3,686 		8,014 +33.4% 0.46 US$3,686
2017-02-21 2017-02-16 B Purchase STRAYER DAVID R

Chief Science/Medical Officer
9,892 +41.3%
0.46
US$4,550 		9,892 +41.3% 0.46 US$4,550
2016-12-23 2016-12-22 B Purchase Equels Thomas K.

CEO, President

Executive Director
68,493 +45.1%
0.73
US$50,000 		68,493 +45.1% 0.73 US$50,000
Explore more

More insider trading research around AIM ImmunoTech Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America